NCT06827197View on ClinicalTrials.gov

Role of Interleukin-1β and Prostaglandin E2 in Prediction and Outcome of Apnea in Neonates

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

October 1, 2023

Study Completion Date

October 30, 2023

Conditions
Premature NewbornsPremature Newborns With Gestational Age 28 to 33 Weeks
Interventions
DIAGNOSTIC_TEST

Blood test

Blood samples were withdrawn from all the neonates under strict aseptic conditions and stored at -80°C for detecting PGE2 and IL-1β levels. PGE2 and IL-1β concentrations were measured using ELISA.

Trial Locations (2)

13511

Benha University, Cairo

Unknown

Amany El-Rebigi, Banhā

All Listed Sponsors
lead

Benha University

OTHER

NCT06827197 - Role of Interleukin-1β and Prostaglandin E2 in Prediction and Outcome of Apnea in Neonates | Biotech Hunter | Biotech Hunter